{"id":"W4410916531","doi":"10.1038/s41591-025-03738-z","title":"Sasanlimab plus BCG in BCG-naive, high-risk non-muscle invasive bladder cancer: the randomized phase 3 CREST trial","year":2025,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Core Research for Evolutional Science and Technology; Pfizer","keywords":"Bladder cancer; Medicine; Crest; Randomized controlled trial; Cancer; Urothelial cancer; Oncology; Internal medicine; Urology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001004707,0.0004814558,0.001753878,0.0004071447,0.0001979569,0.00002079587,0.0003327765,0.0005217598,0.0009039901],"category_scores_gemma":[0.002137633,0.0002596725,0.0002735424,0.001052572,0.0005632289,0.00008459328,0.00008153848,0.001855857,0.00002115342],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004560186,"about_ca_system_score_gemma":0.001269702,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008084915,"about_ca_topic_score_gemma":0.00217916,"domain_scores_codex":[0.9969212,0.0003706674,0.0007973101,0.0006451823,0.0007348637,0.0005307444],"domain_scores_gemma":[0.9970513,0.001500645,0.0002762785,0.0007258769,0.0002499229,0.0001959849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8836436,0.001352688,0.001106542,0.0002156467,0.001987539,0.0004051008,0.002954921,0.00001898005,0.001240779,0.0007423013,0.07439627,0.03193567],"study_design_scores_gemma":[0.9732974,0.00135984,0.003895181,0.001041441,0.002637299,0.00001057906,0.0005586111,0.0001616123,0.001770329,0.001025255,0.01401641,0.0002260009],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8666238,0.04045498,0.0002442718,0.05260246,0.007139583,0.009720898,0.000177309,0.000149184,0.02288754],"genre_scores_gemma":[0.9775457,0.006202286,0.0000927825,0.00954315,0.002298289,0.0009320562,0.0001308511,0.00004652185,0.003208356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1109219,"threshold_uncertainty_score":0.9999856,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01066045220669053,"score_gpt":0.3350979458669067,"score_spread":0.3244374936602161,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}